Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 1.24% is 41% above its 5-year average of 0.88%, near the high end of its 5-year range (-1.73%–1.71%).
As of the fiscal period ended Tuesday, March 31, 2026. 7.97% below its 12-month average of 1.35%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
1.24%
EBITDA MARGIN AVG TTM
1.35%
EBITDA MARGIN AVG 3Y
1.23%
EBITDA MARGIN AVG 5Y
1.01%
EBITDA MARGIN AVG 10Y
1.48%
EBITDA MARGIN AVG 15Y
1.76%
EBITDA MARGIN AVG 20Y
1.84%
CURRENT VS TTM AVG
-7.97%
CURRENT VS 3Y AVG
+0.97%
CURRENT VS 5Y AVG
+22.85%
CURRENT VS 10Y AVG
-16.19%
CURRENT VS 15Y AVG
-29.57%
CURRENT VS 20Y AVG
-32.67%
Cardinal Health, Inc.
Market Cap
$52.85B
EBITDA Margin
1.24%
TTM Avg
1.35%
3Y Avg
1.23%
5Y Avg
1.01%
Market Cap
$49.39B
EBITDA Margin
29.55%
TTM Avg
28.88%
3Y Avg
30.96%
5Y Avg
31.73%
Market Cap
$60.20B
EBITDA Margin
23.08%
TTM Avg
23.14%
3Y Avg
23.23%
5Y Avg
22.53%
Market Cap
$44.36B
EBITDA Margin
34.08%
TTM Avg
33.18%
3Y Avg
32.37%
5Y Avg
31.82%
Market Cap
$39.95B
EBITDA Margin
21.04%
TTM Avg
21.29%
3Y Avg
20.90%
5Y Avg
20.09%
Market Cap
$39.11B
EBITDA Margin
25.43%
TTM Avg
26.12%
3Y Avg
26.05%
5Y Avg
25.37%
Market Cap
$67.03B
EBITDA Margin
26.60%
TTM Avg
24.95%
3Y Avg
24.24%
5Y Avg
23.28%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardinal Health, Inc. (CAH) | $52.85B | 1.24% | 1.35% | 1.23% | 1.01% |
| Edwards Lifesciences Corporation (EW)vs › | $49.39B | 29.55% | 28.88% | 30.96% | 31.73% |
| Becton, Dickinson and Company (BDX)vs › | $60.20B | 23.08% | 23.14% | 23.23% | 22.53% |
| Cencora, Inc. (COR)vs › | $61.02B | 1.46% | 1.44% | 1.41% | 1.40% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.36B | 34.08% | 33.18% | 32.37% | 31.82% |
| Humana Inc. (HUM)vs › | $43.60B | 1.76% | 1.98% | 3.17% | 4.08% |
| IQVIA Holdings Inc. (IQV)vs › | $39.95B | 21.04% | 21.29% | 20.90% | 20.09% |
| Agilent Technologies, Inc. (A)vs › | $39.11B | 25.43% | 26.12% | 26.05% | 25.37% |
| Boston Scientific Corporation (BSX)vs › | $67.03B | 26.60% | 24.95% | 24.24% | 23.28% |
| Medline Inc. (MDLN)vs › | $34.76B | 10.26% | 11.41% | 10.38% | 10.38% |
Gross Margin
3.7%
EBITDA Margin
1.2%
Operating Margin
0.9%
Net Margin
0.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-03-31 | 1.24% |
| 2025-12-31 | 1.33% |
| 2025-09-30 | 1.41% |
| 2025-06-30 | 1.06% |
| 2025-03-31 | 1.71% |
| 2024-12-31 | 1.34% |
| 2024-09-30 | 1.43% |
| 2024-06-30 | 0.99% |
| 2024-03-31 | 1.00% |
| 2023-12-31 | 1.18% |
| 2023-09-30 | 0.26% |
| 2023-06-30 | 0.59% |
| 2023-03-31 | 1.48% |
| 2022-12-31 | 0.10% |
| 2022-09-30 | 0.62% |
| 2022-06-30 | 0.46% |
| 2022-03-31 | 0.19% |
| 2021-12-31 | -1.73% |
| 2021-09-30 | 1.33% |
| 2021-06-30 | 0.80% |
| 2021-03-31 | 1.71% |
| 2020-12-31 | 1.59% |
| 2020-09-30 | -1.07% |
| 2020-06-30 | 1.35% |
| 2020-03-31 | 2.01% |
| 2019-12-31 | 1.42% |
| 2019-09-30 | -13.47% |
| 2019-06-30 | 1.47% |
| 2019-03-31 | 1.97% |
| 2018-12-31 | 2.01% |
| 2018-09-30 | 3.01% |
| 2018-06-30 | -2.34% |
| 2018-03-31 | 2.39% |
| 2017-12-31 | 1.96% |
| 2017-09-30 | 1.50% |
| 2017-06-30 | 1.91% |
| 2017-03-31 | 2.49% |
| 2016-12-31 | 2.14% |
| 2016-09-30 | 2.21% |
| 2016-06-30 | 2.54% |
| 2016-03-31 | 2.66% |
| 2015-12-31 | 2.33% |
| 2015-09-30 | 2.70% |
| 2015-06-30 | 2.44% |
| 2015-03-31 | 2.79% |
| 2014-12-31 | 2.58% |
| 2014-09-30 | 2.38% |
| 2014-06-30 | 2.19% |
| 2014-03-31 | 2.88% |
| 2013-12-31 | 2.86% |
| 2013-09-30 | 2.40% |
| 2013-06-30 | -1.26% |
| 2013-03-31 | 2.34% |
| 2012-12-31 | 2.35% |
| 2012-09-30 | 2.11% |
| 2012-06-30 | 1.83% |
| 2012-03-31 | 2.27% |
| 2011-12-31 | 1.95% |
| 2011-09-30 | 1.83% |
| 2011-06-30 | 1.62% |
| 2011-03-31 | 2.09% |
| 2010-12-31 | 1.64% |
| 2010-09-30 | 1.77% |
| 2010-06-30 | 1.61% |
| 2010-03-31 | 1.79% |
| 2009-12-31 | 1.71% |
| 2009-09-30 | 1.24% |
| 2009-06-30 | 2.11% |
| 2009-03-31 | 1.80% |
| 2008-12-31 | 1.58% |
| 2008-09-30 | 1.43% |
| 2008-06-30 | 2.76% |
| 2008-03-31 | 2.92% |
| 2007-12-31 | 2.65% |
| 2007-09-30 | 2.66% |
| 2007-06-30 | 2.27% |
| 2007-03-31 | 0.33% |
| 2006-12-31 | 2.70% |
| 2006-09-30 | 2.53% |
| 2006-06-30 | 2.93% |
| 2006-03-31 | 3.01% |
| 2005-12-31 | 2.59% |
| 2005-09-30 | 2.48% |
| 2005-06-30 | 3.13% |
| 2005-03-31 | 3.59% |
| 2004-12-31 | 2.31% |
| 2004-09-30 | 2.54% |
| 2004-06-30 | 3.79% |
| 2004-03-31 | 4.54% |
| 2003-12-31 | 4.03% |
| 2003-09-30 | 3.84% |
| 2003-06-30 | 4.25% |
| 2003-03-31 | 4.71% |
| 2002-12-31 | 4.65% |
| 2002-09-30 | 4.05% |
| 2002-06-30 | 4.09% |